Your browser doesn't support javascript.
COVID-19 and tuberculosis-threats and opportunities.
Zumla, Alimuddin; Marais, B J; McHugh, T D; Maeurer, M; Zumla, Adam; Kapata, N; Ntoumi, F; Chanda-Kapata, P; Mfinanga, S; Centis, R; Cirillo, D M; Petersen, E; Hui, D S; Ippolito, G; Leung, C C; Migliori, G B; Tiberi, S.
  • Zumla A; Center for Clinical Microbiology, Division of Infection and Immunity, University College London, Royal Free Hospital Campus, London, UK.
  • Marais BJ; Marie Bashir Institute for Emerging Infectious Diseases and Biosecurity, University of Sydney, Sydney NSW, Australia.
  • McHugh TD; Center for Clinical Microbiology, Division of Infection and Immunity, University College London, Royal Free Hospital Campus, London, UK.
  • Maeurer M; Immunotherapy Programme, Champalimaud Centre for the Unknown, Lisbon, Portugal, I Med Clinic, University of Mainz, Mainz, Germany.
  • Zumla A; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Kapata N; Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia.
  • Ntoumi F; Foundation Congolaise pour la Recherche Médicale/University Marien Ngouabi Brazzaville, Congo, Institute for Tropical Medicine/University of Tübingen, Germany.
  • Chanda-Kapata P; Ministry of Health, Lusaka, Zambia.
  • Mfinanga S; National Institute of Medical Research, Dar es Salaam, Tanzania.
  • Centis R; Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Varese.
  • Cirillo DM; Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Petersen E; Institute for Clinical Medicine, Faculty of Health Sciences, University of Aarhus, Denmark, Department of Melecular Medicine, University of Pavia, Italy.
  • Hui DS; Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China.
  • Ippolito G; Lazzaro Spallanzani, National Institute for Infectious Diseases IRCCS, Rome, Italy.
  • Leung CC; Hong Kong Tuberculosis, Chest and Heart Diseases Association, Hong Kong, China.
  • Migliori GB; Ministry of Health, Lusaka, Zambia.
  • Tiberi S; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK, <email></email>, Email: simon.tiberi@nhs.net.
Int J Tuberc Lung Dis ; 24(8): 757-760, 2020 08 01.
Article in English | MEDLINE | ID: covidwho-761041
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Tuberculosis, Pulmonary / Global Health / Coronavirus Infections / Pandemics Type of study: Observational study Limits: Humans Language: English Journal: Int J Tuberc Lung Dis Year: 2020 Document Type: Article Affiliation country: Ijtld.20.0387

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Tuberculosis, Pulmonary / Global Health / Coronavirus Infections / Pandemics Type of study: Observational study Limits: Humans Language: English Journal: Int J Tuberc Lung Dis Year: 2020 Document Type: Article Affiliation country: Ijtld.20.0387